Why is VRDN Down Today?
About Viridian Therapeutics, Inc. Common Stock
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutane...
Overall Confidence: 67%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
NORMAL - This move is backed by significant volume and appears sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -2.4%
Market Comparison
Quick Trade Ideas
Options strategies to consider for VRDN's -6% move
No Options Available
VRDN doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get VRDN Alerts
We'll notify you when VRDN's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
VRDN has moved more than 3.0% down on 31 occasions in the past year.
Frequently Asked Questions
Why is VRDN stock down today?
This appears to be a sector-wide move. The PHARMACEUTICAL PREPARATIONS sector is down 2.4% on average.
Is VRDN stock a buy or sell right now?
Based on current analysis, VRDN shows 67% confidence in today's move. Volume is moderate which supports the trend. View full buy/sell analysis →
What is the VRDN stock price target?
VRDN is currently trading at $19.29. Based on today's momentum, the expected short-term range is $18.71 - $19.67. See long-term price prediction →
Will VRDN stock continue falling?
Our analysis shows a 45% probability that VRDN's move continues in the next 1-3 days. Key level to watch: $18.32 (support).
Is VRDN stock oversold or overbought?
VRDN's RSI (Relative Strength Index) is currently at 32.4. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for VRDN stock?
VRDN's 10-day momentum indicator is at -2.94. Strong bearish momentum - the stock is experiencing significant downward pressure. Watch for potential reversal signals.
Is VRDN outperforming or underperforming the market?
VRDN (-6.34%) is currently significantly underperforming the market (-6.5% vs SPY). Today, the S&P 500 (SPY) is up 0.18%, and Nasdaq (QQQ) is up 0.31%.
What does MACD indicate for VRDN?
VRDN's MACD (-0.65) is currently below the signal line (-0.35), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 23.8) is moderate.
Is VRDN in an uptrend or downtrend?
Based on moving average analysis, VRDN is in a bearish trend. The price ($19.29) is trading below both the 20-day SMA ($21.61) and 50-day SMA ($21.96). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis